CANF - Can-Fite BioPharma Ltd.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts2222
Avg. Estimate-0.08-0.09-0.28-0.5
Low Estimate-0.08-0.1-0.29-0.61
High Estimate-0.08-0.08-0.27-0.39
Year Ago EPS-0.3-0.12N/A-0.28
Revenue EstimateCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
No. of Analysts2222
Avg. Estimate40k40k230k200k
Low EstimateN/AN/A150kN/A
High Estimate80k80k310k400k
Year Ago Sales60kN/AN/A230k
Sales Growth (year/est)-33.30%N/AN/A-13.00%
Earnings History9/29/20153/30/20166/29/20166/29/2017
EPS Est.-0.04-0.09-0.09-0.08
EPS Actual-0.3-0.12-0.08-0.06
Difference-0.26-0.030.010.02
Surprise %-650.00%-33.30%11.10%25.00%
EPS TrendCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Current Estimate-0.08-0.09-0.28-0.5
7 Days Ago-0.08-0.09-0.28-0.5
30 Days Ago-0.08-0.09-0.28-0.5
60 Days Ago-0.08-0.09-0.3-0.49
90 Days Ago-0.08-0.09-0.3-0.49
EPS RevisionsCurrent Qtr. (Sep 2017)Next Qtr. (Dec 2017)Current Year (2017)Next Year (2018)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 DaysN/AN/A1N/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesCANFIndustrySectorS&P 500
Current Qtr.73.30%N/AN/A0.22
Next Qtr.25.00%N/AN/A0.25
Current YearN/AN/AN/A0.08
Next Year-78.60%N/AN/A0.12
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A